Seongnam, South Korea

Jhin-gook Kim

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2009.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jhin-gook Kim in Lung Cancer Prediction

Introduction

Jhin-gook Kim is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of cancer research. His innovative work focuses on predicting the risk of lung cancer recurrence, which is crucial for patient management and treatment strategies.

Latest Patents

Jhin-gook Kim holds a patent for a method of predicting the risk of lung cancer recurrence. This patent includes a comprehensive approach that involves obtaining a biological sample from a lung cancer patient. The method measures the expression level of at least one marker gene from the sample, which is selected from a specific group of marker genes. The data obtained is then used to determine whether the expression level corresponds to a recurrence group or a non-recurrence group. This innovative method has the potential to significantly improve patient outcomes by providing critical information for treatment decisions.

Career Highlights

Jhin-gook Kim is currently employed at Samsung Electronics Co., Ltd., where he applies his expertise in medical technology and innovation. His work at Samsung has allowed him to collaborate with leading professionals in the field, enhancing the impact of his research.

Collaborations

Some of Jhin-gook Kim's coworkers include Byung-Chul Kim and Nam Hwi Hur. Their collaboration has fostered a productive environment for innovation and research in cancer prediction technologies.

Conclusion

Jhin-gook Kim's contributions to the field of lung cancer research through his innovative patent demonstrate his commitment to improving patient care. His work not only advances medical technology but also holds promise for better management of lung cancer recurrence.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…